About Neurawell Therapeutics
Neurawell Therapeutics is a private company based in Sunny Isles Beach, Florida. It has reported $1,619,999 raised in one offering on Form D since June 2024. Its chief executive is Magid Abraham.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| May 20, 2024 | Jun 10, 2024 | $1,619,999of $3.0M target | 4 | $404K | EquityRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Neurawell Therapeutics's Form D filed Jun 10, 2024.
JA
Jack Abraham
Director
MA
Magid Abraham
Chief Executive Officer and director
TI
Tom Insel
Executive officer and director